meglumine antimoniate has been researched along with Diathesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boudaya, S; Maalej, N; Masmoudi, A; Turki, H; Zahaf, A | 1 |
| Aragort de Rossell, R; de Jesús de Durán, R; Rodríguez, AM; Rossell, O | 1 |
2 other study(ies) available for meglumine antimoniate and Diathesis
| Article | Year |
|---|---|
[Adverse effects of intralesional Glucantime in the treatment of cutaneous leishmaniosis].
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Disease Susceptibility; Drug Eruptions; Facial Dermatoses; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Assessment; Sporotrichosis; Staphylococcal Skin Infections; Superinfection | 2006 |
Thermotherapy v. antimonials: what happens after the healing of cutaneous leishmaniasis lesions?
Topics: Animals; Antiprotozoal Agents; Disease Susceptibility; Female; Hyperthermia, Induced; Immunologic Memory; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organometallic Compounds; Recurrence | 1993 |